Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Nechansky

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|August 15, 2009
HAHA--nothing to laugh about. Measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technologyAndreas Nechansky
Expert Opinion on Drug Discovery|July 26, 2012
Immunogenicity of therapeutics: a matter of efficacy and safetyAndreas Nechansky, Ralf Kircheis
Biotechnology Journal|August 8, 2006
Cancer immunotherapyManfred Schuster, Andreas Nechansky, Ralf Kircheis
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
In Response to: 'Impact of Glycosylation on Effector Functions of Therapeutic IgG' (Pharmaceuticals 2010, 3, 146-157)Andreas Nechansky, Iris Koller, Ralf Kircheis
Microarrays (Basel, Switzerland)|December 29, 2016
Application of Lectin Array Technology for Biobetter Characterization: Its Correlation with FcγRIII Binding and ADCCMarkus Roucka, Klaus Zimmermann, Markus Fido, et al.
Biomarker Insights|July 7, 2009
Comparison of the Calibration Standards of Three Commercially Available Multiplex Kits for Human Cytokine Measurement to WHO Standards Reveals Striking DifferencesAndreas Nechansky, Susanne Grunt, Ivan M Roitt, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 16, 2009
Qualification of a microfluidics-based electrophoretic method for impurity testing of monoclonal antibodiesBernhard Antes, Philipp Oberkleiner, Andreas Nechansky, et al.
Molecular Immunology|October 3, 2006
Compensation of endogenous IgG mediated inhibition of antibody-dependent cellular cytotoxicity by glyco-engineering of therapeutic antibodiesAndreas Nechansky, Manfred Schuster, Wolfgang Jost, et al.
Cancer Immunology, Immunotherapy : CII|September 30, 2006
Immunization of Rhesus monkeys with a SialylTn-mAb17-1A conjugate vaccine co-formulated with QS-21 induces a temporary systemic cytokine release and NK cytotoxicity against tumor cellsRalf Kircheis, Petra Siegl, Susanne Grunt, et al.
Bioconjugate Chemistry|November 17, 2005
SialylTn-mAb17-1A carbohydrate-protein conjugate vaccine: effect of coupling density and presentation of SialylTnRalf Kircheis, Petra Vondru, Andreas Nechansky, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Pharmaceutical and Biomedical Analysis|August 15, 2009
HAHA--nothing to laugh about. Measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technologyAndreas Nechansky
Expert Opinion on Drug Discovery|July 26, 2012
Immunogenicity of therapeutics: a matter of efficacy and safetyAndreas Nechansky, Ralf Kircheis
Biotechnology Journal|August 8, 2006
Cancer immunotherapyManfred Schuster, Andreas Nechansky, Ralf Kircheis
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
In Response to: 'Impact of Glycosylation on Effector Functions of Therapeutic IgG' (Pharmaceuticals 2010, 3, 146-157)Andreas Nechansky, Iris Koller, Ralf Kircheis
Microarrays (Basel, Switzerland)|December 29, 2016
Application of Lectin Array Technology for Biobetter Characterization: Its Correlation with FcγRIII Binding and ADCCMarkus Roucka, Klaus Zimmermann, Markus Fido, et al.
Biomarker Insights|July 7, 2009
Comparison of the Calibration Standards of Three Commercially Available Multiplex Kits for Human Cytokine Measurement to WHO Standards Reveals Striking DifferencesAndreas Nechansky, Susanne Grunt, Ivan M Roitt, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 16, 2009
Qualification of a microfluidics-based electrophoretic method for impurity testing of monoclonal antibodiesBernhard Antes, Philipp Oberkleiner, Andreas Nechansky, et al.
Molecular Immunology|October 3, 2006
Compensation of endogenous IgG mediated inhibition of antibody-dependent cellular cytotoxicity by glyco-engineering of therapeutic antibodiesAndreas Nechansky, Manfred Schuster, Wolfgang Jost, et al.
Cancer Immunology, Immunotherapy : CII|September 30, 2006
Immunization of Rhesus monkeys with a SialylTn-mAb17-1A conjugate vaccine co-formulated with QS-21 induces a temporary systemic cytokine release and NK cytotoxicity against tumor cellsRalf Kircheis, Petra Siegl, Susanne Grunt, et al.
Bioconjugate Chemistry|November 17, 2005
SialylTn-mAb17-1A carbohydrate-protein conjugate vaccine: effect of coupling density and presentation of SialylTnRalf Kircheis, Petra Vondru, Andreas Nechansky, et al.
Pageof 2